PL3909568T3 - Lek profilaktyczny lub terapeutyczny dla chorób neurodegeneracyjnych - Google Patents
Lek profilaktyczny lub terapeutyczny dla chorób neurodegeneracyjnychInfo
- Publication number
- PL3909568T3 PL3909568T3 PL20738553.5T PL20738553T PL3909568T3 PL 3909568 T3 PL3909568 T3 PL 3909568T3 PL 20738553 T PL20738553 T PL 20738553T PL 3909568 T3 PL3909568 T3 PL 3909568T3
- Authority
- PL
- Poland
- Prior art keywords
- preventive
- neurodegenerative diseases
- therapeutic drug
- therapeutic
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2019/000278 WO2020144753A1 (ja) | 2019-01-09 | 2019-01-09 | 神経変性疾患の予防又は治療薬 |
| PCT/JP2020/000392 WO2020145331A1 (ja) | 2019-01-09 | 2020-01-09 | 神経変性疾患の予防又は治療薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3909568T3 true PL3909568T3 (pl) | 2025-01-20 |
Family
ID=71520264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20738553.5T PL3909568T3 (pl) | 2019-01-09 | 2020-01-09 | Lek profilaktyczny lub terapeutyczny dla chorób neurodegeneracyjnych |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US12521387B2 (pl) |
| EP (1) | EP3909568B1 (pl) |
| JP (1) | JP7279958B2 (pl) |
| KR (1) | KR102896709B1 (pl) |
| CN (1) | CN113260357B (pl) |
| BR (1) | BR112021013582A2 (pl) |
| CA (1) | CA3125913A1 (pl) |
| DK (1) | DK3909568T3 (pl) |
| ES (1) | ES2989515T3 (pl) |
| FI (1) | FI3909568T3 (pl) |
| HU (1) | HUE069327T2 (pl) |
| MX (1) | MX2021008329A (pl) |
| PL (1) | PL3909568T3 (pl) |
| PT (1) | PT3909568T (pl) |
| TW (1) | TWI833874B (pl) |
| WO (2) | WO2020144753A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
| WO2025225629A1 (ja) * | 2024-04-23 | 2025-10-30 | 株式会社メディラボRfp | 経鼻投与用組成物 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004222529A1 (en) * | 2003-03-19 | 2004-09-30 | Ares Trading S.A. | INF-beta alone or in combination with other medicaments for treating Alzheimer's disease and demens disorders |
| EP1850840A2 (en) | 2005-01-13 | 2007-11-07 | Sirtris Pharmaceuticals, Inc. | Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders |
| US20070014833A1 (en) | 2005-03-30 | 2007-01-18 | Sirtris Pharmaceuticals, Inc. | Treatment of eye disorders with sirtuin modulators |
| EP2805719A1 (en) | 2005-03-30 | 2014-11-26 | Glaxosmithkline LLC | Nicotinamide riboside and analogues thereof |
| US20060292099A1 (en) | 2005-05-25 | 2006-12-28 | Michael Milburn | Treatment of eye disorders with sirtuin modulators |
| US20070149466A1 (en) | 2005-07-07 | 2007-06-28 | Michael Milburn | Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders |
| US7837832B2 (en) | 2005-12-15 | 2010-11-23 | Dow Global Technologies, Inc. | Additive compositions for treating various base sheets |
| US7842163B2 (en) | 2005-12-15 | 2010-11-30 | Kimberly-Clark Worldwide, Inc. | Embossed tissue products |
| US7803250B2 (en) | 2005-12-15 | 2010-09-28 | Dow Global Technologies, Inc. | Wiping products having enhanced cleaning abilities |
| US7803249B2 (en) | 2005-12-15 | 2010-09-28 | Dow Global Technologies Inc. | Wiping products with controlled lint properties |
| US7879188B2 (en) | 2005-12-15 | 2011-02-01 | Kimberly-Clark Worldwide, Inc. | Additive compositions for treating various base sheets |
| US20070137811A1 (en) | 2005-12-15 | 2007-06-21 | Kimberly-Clark Worldwide, Inc. | Premoistened tissue products |
| US7678231B2 (en) | 2005-12-15 | 2010-03-16 | Dow Global Technologies, Inc. | Process for increasing the basis weight of sheet materials |
| US8282776B2 (en) | 2005-12-15 | 2012-10-09 | Kimberly-Clark Worldwide, Inc. | Wiping product having enhanced oil absorbency |
| US7879191B2 (en) | 2005-12-15 | 2011-02-01 | Kimberly-Clark Worldwide, Inc. | Wiping products having enhanced cleaning abilities |
| US7879189B2 (en) | 2005-12-15 | 2011-02-01 | Kimberly-Clark Worldwide, Inc. | Additive compositions for treating various base sheets |
| US7807023B2 (en) | 2005-12-15 | 2010-10-05 | Kimberly-Clark Worldwide, Inc. | Process for increasing the basis weight of sheet materials |
| US8444811B2 (en) | 2005-12-15 | 2013-05-21 | Kimberly-Clark Worldwide, Inc. | Process for increasing the basis weight of sheet materials |
| US7883604B2 (en) | 2005-12-15 | 2011-02-08 | Kimberly-Clark Worldwide, Inc. | Creping process and products made therefrom |
| US7837831B2 (en) | 2005-12-15 | 2010-11-23 | Kimberly-Clark Worldwide, Inc. | Tissue products containing a polymer dispersion |
| US7820010B2 (en) | 2005-12-15 | 2010-10-26 | Kimberly-Clark Worldwide, Inc. | Treated tissue products having increased strength |
| US20080075671A1 (en) | 2006-09-22 | 2008-03-27 | Di Mauro Thomas M | Intranasally administering curcumin to the brain to treat alzheimer's disease |
| US20090087385A1 (en) | 2006-09-22 | 2009-04-02 | Di Mauro Thomas M | Intranasally administering curcumin in a bolus of helium gas to treat alzheimers disease |
| EP2749552B1 (en) | 2007-04-17 | 2015-11-18 | Codman & Shurtleff, Inc. | Curcumin-resveratrol hybrids |
| US8383865B2 (en) | 2007-04-17 | 2013-02-26 | Codman & Shurtleff, Inc. | Curcumin derivatives |
| GB2463833B (en) * | 2007-06-26 | 2012-02-08 | Parkinson S Inst | Compositions that prevent or reverse alpha-synuclein fibrillation for use in the treatment of neurological disorders |
| US7745670B2 (en) | 2008-06-27 | 2010-06-29 | Codman & Shurtleff, Inc. | Curcumin-Resveratrol hybrid molecule |
| US20090324740A1 (en) * | 2008-06-13 | 2009-12-31 | Albritton Iv Ford D | Novel nasal spray |
| US7985776B2 (en) | 2008-06-27 | 2011-07-26 | Codman & Shurtleff, Inc. | Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease |
| GB2480159A (en) * | 2008-11-14 | 2011-11-09 | Parkinson S Inst | Compositions and methods for the treatment of altered a-synuclein function |
| WO2010095926A1 (en) * | 2009-02-20 | 2010-08-26 | N.V. Nutricia | Use of reveratrol for preserving cognitive functioning |
| JP2013518034A (ja) * | 2010-01-21 | 2013-05-20 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 薬物として使用するための特別な組成物 |
| BRPI1001052A2 (pt) * | 2010-04-22 | 2011-12-13 | União Brasileira De Educação E Assistência - Mantenedora Da Puc Rs | formulação farmacêutica e processo para reduzir hepatotoxicidade |
| US20120058088A1 (en) | 2010-06-28 | 2012-03-08 | Resveratrol Partners, Llc | Resveratrol-Containing Compositions And Methods Of Use |
| WO2012054936A1 (en) | 2010-10-22 | 2012-04-26 | Barber Elizabeth K | Treatment of neurodegenerative disease |
-
2019
- 2019-01-09 WO PCT/JP2019/000278 patent/WO2020144753A1/ja not_active Ceased
-
2020
- 2020-01-09 ES ES20738553T patent/ES2989515T3/es active Active
- 2020-01-09 PL PL20738553.5T patent/PL3909568T3/pl unknown
- 2020-01-09 TW TW109100789A patent/TWI833874B/zh active
- 2020-01-09 PT PT207385535T patent/PT3909568T/pt unknown
- 2020-01-09 WO PCT/JP2020/000392 patent/WO2020145331A1/ja not_active Ceased
- 2020-01-09 JP JP2020565193A patent/JP7279958B2/ja active Active
- 2020-01-09 BR BR112021013582-0A patent/BR112021013582A2/pt unknown
- 2020-01-09 CN CN202080008071.XA patent/CN113260357B/zh active Active
- 2020-01-09 MX MX2021008329A patent/MX2021008329A/es unknown
- 2020-01-09 HU HUE20738553A patent/HUE069327T2/hu unknown
- 2020-01-09 EP EP20738553.5A patent/EP3909568B1/en active Active
- 2020-01-09 CA CA3125913A patent/CA3125913A1/en active Pending
- 2020-01-09 DK DK20738553.5T patent/DK3909568T3/da active
- 2020-01-09 FI FIEP20738553.5T patent/FI3909568T3/fi active
- 2020-01-09 US US17/421,686 patent/US12521387B2/en active Active
- 2020-01-09 KR KR1020217023135A patent/KR102896709B1/ko active Active
-
2025
- 2025-12-15 US US19/420,573 patent/US20260102392A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN113260357A (zh) | 2021-08-13 |
| BR112021013582A2 (pt) | 2021-09-21 |
| EP3909568A4 (en) | 2022-07-27 |
| WO2020145331A1 (ja) | 2020-07-16 |
| US20260102392A1 (en) | 2026-04-16 |
| US20220125782A1 (en) | 2022-04-28 |
| PT3909568T (pt) | 2024-10-17 |
| CN113260357B (zh) | 2024-11-15 |
| KR102896709B1 (ko) | 2025-12-08 |
| DK3909568T3 (da) | 2024-09-30 |
| EP3909568B1 (en) | 2024-09-18 |
| HUE069327T2 (hu) | 2025-02-28 |
| EP3909568A1 (en) | 2021-11-17 |
| TW202042793A (zh) | 2020-12-01 |
| WO2020144753A1 (ja) | 2020-07-16 |
| JPWO2020145331A1 (ja) | 2021-11-25 |
| US12521387B2 (en) | 2026-01-13 |
| CA3125913A1 (en) | 2020-07-16 |
| ES2989515T3 (es) | 2024-11-26 |
| KR20210113240A (ko) | 2021-09-15 |
| JP7279958B2 (ja) | 2023-05-23 |
| FI3909568T3 (fi) | 2024-10-08 |
| MX2021008329A (es) | 2021-08-05 |
| TWI833874B (zh) | 2024-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3717471T3 (da) | Nye forbindelser og lægemiddelsammensætninger heraf til behandling af sygdomme | |
| SG11202104923YA (en) | Pharmaceutical combination for treatment of cancer | |
| PT3600309T (pt) | Combinações terapêuticas para o tratamento de doenças hepáticas | |
| PL3416631T3 (pl) | Środki terapeutyczne do leczenia chorób neurodegeneracyjnych | |
| DK3478679T3 (da) | 5,7-dihydro-pyrrolo-pyridin-derivater til behandling af neurologiske og neurodegenerative sygdomme | |
| IL288001A (en) | Compounds for the treatment of neurodegenerative and metabolic disorders | |
| SG11201801024XA (en) | Therapeutic or preventive compositions for il-8-related diseases | |
| IL281244A (en) | Combination therapy for the treatment of liver disease | |
| IL286340A (en) | Topical formulations for treatment of peripheral neuropathies | |
| EP3573614C0 (en) | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | |
| IL272601A (en) | Pharmaceutical compositions for the treatment of ophthalmic conditions | |
| IL280664A (en) | 2-arylbenzimidazoles as ppargc1a activators for treating neurodegenerative diseases | |
| HUE059584T2 (hu) | Gyógyszerészeti készítmény vérszegénység kezelésére | |
| DK3430143T3 (da) | Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme | |
| EP3659136A4 (en) | AUTOMATED DISEASE EVALUATION | |
| IL281869A (en) | Therapeutic agent for neurodegenerative disease | |
| DK3578562T3 (da) | L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme | |
| EP3843773A4 (en) | Inhibition of rip kinases for treating neurodegenerative disorders | |
| PL3424499T3 (pl) | Kompozycja farmaceutyczna do leczenia bólu neuropatycznego | |
| DK3773595T3 (da) | Farmaceutiske anticancer-sammensætninger til kombineret terapi | |
| DK3403674T3 (da) | Farmaceutiske sammensætninger til behandling af smerte | |
| PL3909568T3 (pl) | Lek profilaktyczny lub terapeutyczny dla chorób neurodegeneracyjnych | |
| MA50383A (fr) | Agents thérapeutiques pour maladies neurodégénératives | |
| IL257336B (en) | Pharmaceutical compounds and preparations for the prevention or treatment of parasitic diseases | |
| IT201700121764A1 (it) | Composizione per il trattamento e/o la prevenzione di patologie neurodegenerative. |